Iodine

Selected References

Abel MH, et al. 2017. Suboptimal maternal iodine intake is associated with impaired child neurodevelopment at 3 years of age in the Norwegian Mother and Child Cohort Study. J Nutr, 147(7):1314-1324.
Alexander EK, et al. 2017. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid, 27(3):315-389.
Andersson M, Braegger CP. 2022. The role of iodine for thyroid function in lactating women and infants. Endocr Rev, 43(3):469-506.
Council on Environmental Health. Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem. Pediatrics, 133:1163-1166.
Hamby T, et al. 2018. Maternal iodine excess: an uncommon cause of acquired neonatal hypothyroidism. J Pediatr Endocrinol Metab, 31(9):1061-1064.
Kerver JM, et al. 2021. Prevalence of inadequate and excessive iodine intake in a US pregnancy cohort. Am J Obstet Gynecol, 224(1):82.e1-82.e8.
Leung AM, et al. 2009. Iodine content of prenatal multivitamins in the United States. N Engl J Med, 360(9):939-940.
Melse-Boonstra A, Mackenzie I. 2013. Iodine deficiency, thyroid function and hearing deficit: a review. Nutr Res Rev, 26(2):110-117.
Næss S, et al. 2023. Infant iodine status and associations with maternal iodine nutrition, breast-feeding status and thyroid function. The British journal of nutrition, 129(5):854–863.
Obican SG, et al. 2012. Teratology public affairs committee position paper: Iodine deficiency in pregnancy. Birth Defects Res A Clin Mol Teratol, 94(9):677-82.
Partal-Lorente AB, et al. 2017. Iodine is associated to semen quality in men who undergo consultations for infertility. Reprod Toxicol, 73:1-7.
Pawlak R, et al. 2023. Prevalence and predictors of low breast milk iodine concentration in women following vegan, vegetarian, and omnivore diets. Breastfeeding Medicine 18(1):37-42.
Pérez-López FR. 2007. Iodine and thyroid hormones during pregnancy and postpartum. Gynecol Endocrinol, 23(7):414-428.
Petersen E, et al. 2020. Iodine status of breastfed infants and their mothers’ breast milk iodine concentration. Matern Child Nutr, 16(3):e12993.
Purdue-Smithe AC, et al. 2022. Iodine and thyroid status during pregnancy and risk of stillbirth: A population-based nested case-control study. Matern Child Nutr, 18(1):e13252.
Soldin OP, et al. 2003. Urinary iodine percentile ranges in the United States. Clin Chim Acta, 328(1-2):185-90.
Thomas Jde V, Collett-Solberg PF. 2009. Perinatal goiter with increased iodine uptake and hypothyroidism due to excess maternal iodine ingestion. Horm Res, 72(6):344-7.
Yang J, et al. 2017. Maternal iodine status during lactation and infant weight and length in Henan Province, China. BMC Pregnancy Childbirth. 17(1):383.
Zhao W, et al. 2019. Iodine nutrition during pregnancy. Biol Trace Elem Res, 188(1): 196-207.
Zimmermann MB. 2007. The impact of iodized salt or iodine supplements on iodine status during pregnancy, lactation and infancy. Public Health Nutr, 10(12A):1584-1595.

Iodine

Selected References:

Amber MR, et al. 2015. Safety of popular herbal supplements in lactating women. J Hum Lact, 31(3):348-353.
Ashar BH and Rowland-Seymour A. 2008. Advising patients who use dietary supplements. Am J Med, 121(2):91-97.
Balbontin YM, et al. 2019. Herbal medicinal product use during pregnancy and the postnatal period. Obstetrics and gynecology, 133(5):920-932.
Bruno LO et al. 2018. Pregnancy and herbal medicines: an unnecessary risk for women’s health. Phytotherapy Research, 32(5):796-810.
Ciganda C and Laborde A. 2003. Herbal infusions used for induced abortion. J Toxicol Clin Toxicol, 41(3):235-239.
Dante G, et al. 2013. Herb remedies during pregnancy: a systematic review of controlled clinical trials. J Maternal-Fetal and Neonatal Med, 26(3): 306-312.
Dante G et al. 2014. Herbal therapies in pregnancy: what works? Curr Opin Obstet Gynecol, 26:83-91.
Frawley J et al. 2015. Women’s use and self-prescription of herbal medicine during pregnancy: an examination of 1,835 pregnant women. Women’s Health Issues, 25(4):396-402.
Kim KH, et al. 2018. Characteristics and outcomes of female infertility treatment programs using traditional medicine in Korea: a multisite analysis. J Alternative and Complimentary Medicine, 24(6):570-577.
Lei HL, et al. 2015. Relationship between risk factors for infertility in women and lead, cadmium, and arsenic blood levels: a cross-sectional study from Taiwan. BMC Public Health, 15:1220.
Newmaster SG, et al. 2013. DNA Barcoding detects contamination and substitution in North American herbal products. BMC Medicine, 11:222.
Smeriglio A, et al. 2014. Herbal products in pregnancy: experimental studies and clinical reports. Phytother Res, 28:1107-1116.
Trabace L, et al. 2015. “Natural” relief of pregnancy-related symptoms and neonatal outcomes: above all do no harm. J Ethnopharmacol 174:396-402.
Wang CC, et al. 2013. Pregnancy outcomes, embryonic and fetal development in maternal exposure to Chinese medicines. Birth Defects Res (Part C), 99:275-291.
Zamawe C, et al. 2018. Effectiveness and safety of herbal medicines for induction of labour: a systematic review and meta-analysis. BMJ Open. 9(10):1-9.

Iodine

Selected References

Bernigaud C, et al. 2020. The Management of Scabies in the 21 st Century: Past, Advances and Potentials. Acta dermato-venereologica, 100.
Bowden VR. 2012. Losing the louse: how to manage this common infestation in children. Pediatr Nurs, 38(5):253- 254, 277.
Chan R & Hoyt-Austin AE. 2024. Scabies Infection While Expressing Human Milk for Critically Ill Infants: Is It Safe?. Breastfeeding medicine: the official journal of the Academy of Breastfeeding Medicine, 19(4):306–308.
Cole SW, et al. 2011. Spinosad for treatment of head lice infestation. Pharmacother 45.7-8: 954-959.Clin Infect Dis. (2002) 35 (Supplement 2): S146-S151.
Dzierzawski A. 1977. Embryo-toxicity studies of lindane in the golden hamster, rat and rabbit. Bull Vet Inst Pulawy, 21:85-93.
Gunning K, et al. 2019. Lice and Scabies: Treatment Update. Am Fam Physician, 99(10):635-642.
Gupta P. 1990. Teratogenic effects of cypermethrin in rats. J Environ Biol, 11(2):121-126.
Hale, T. 2006. Medications and Mothers’ Milk. Amarillo, TX: Hale Publishing.
Kennedy D, et al. 2005. Pregnancy outcome following exposure to permethrin and use of teratogen information. Am J Perinatol, 22(2):87-90.
Khera K, et al. 1982. Teratogenicity study on pyrethrum and rotenone (natural origin) in pregnant rats. J Toxicol Environ Health, 10:111-119.
Khera K, et al. 1978 Teratogenicity studies on linuron, malathion, and methoxychlor in rats. Toxicol Appl Pharmacol, 45:435-444.
Leachman SA, et al. 2006. The use of dermatologic drugs in pregnancy and lactation. Derm clin, 24.2:167-197.
Miyamoto J. 1976 Degradation, metabolism and toxicity of synthetic pyrethroids. Environ Health Criter, 14:15-28.
Morand A, et al. 2024. Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology. The British journal of dermatology, 191(6):1014–1016.
Murase JE, et al. 2014. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Amer Aca of Derm, 70:401-e1.
Mytton OT, et al. 2007. Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG, 114(5):582-587.
Nicolas P, et al. 2020. Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health, 8:e92–e100.
Ogbuokiri J, et al. 1994. Ivermectin levels in human breast milk [letter]. Eur J Clin Pharmacol, 46:89-90.
Pacque M, et al. 1990. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. The Lancet, 336.8729:1486-1489.
Patel VM, et al. 2016. Safety of topical medications for scabies and lice in pregnancy. Ind J of Derm, 61(6): 583.
Porto I. 2003. Antiparasitic drugs & lactation: focus on anthelmintics, scabicides, & pediculosis. J Hum Lact, 19:421-5.
Rosumeck S, et al. 2018. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev 4
Salavastru CM, et al. 2017. European guideline for the management of scabies. J Eur Acad Dermatol Venereol JEADV, 31:1248–1253.
Sánchez-Díaz M, et al. 2024. European survey on the management of scabies by dermatologists in children under 2 months, pregnancy and breastfeeding woman. Journal of the European Academy of Dermatology and Venereology, 38(11):e950–e953.
Sciammarella J. Scabies. Retrieved November 2014 from: http://www.emedicine.com/EMERG/topic517.htm.
Strong M, et al. 2007. Interventions for treating scabies. Cochrane Database Syst Rev, 3.
Sunderkötter C, et al. 2021. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int, 118(41):695-704. PMID: 34615594 PMCID: PMC8743988 DOI: 10.3238/arztebl.m2021.0296
The Centers for Disease Control and Prevention (CDC). 2019. Parasites –Lice – Treatment. [Accessed 4/2021]. Available at URL: https://www.cdc.gov/parasites/lice/head/treatment.html
The Centers for Disease Control and Prevention (CDC). 2019. Parasites –Scabies -Medication. [Accessed 4/2021]. Available at URL: https://www.cdc.gov/parasites/scabies/health_professionals/meds.html
The Centers for Disease Control and Prevention (CDC). 2010. Parasites–Scabies. Available at URL: https://www.cdc.gov/parasites/scabies/index.html [Accessed 5/2023].
Weill A et al. 2021. Scabies-infested pregnant women: A critical therapeutic challenge. PLOS Neglected Trop Dis, 15.1: e0008929.

Iodine

Selected References:

Abdullah K., et al. 2020. Effect of asthma exacerbation during pregnancy in women with asthma: A population-based cohort study. The European Respiratory Journal, 55(2), 1901335.
Ali Z. 2017. Asthma and Pregnancy: Possible to prevent complications?- With Special reference to the impact of obesity and type of airway inflammation. Dan Med J. 64(12):B5428
Bláfoss, J. et al. 2019. Female asthma and atopy – impact on fertility: A systematic review. Journal of Asthma and Allergy, 12, 205–211.
Blais L, et al. 2010. Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study. Birth Defects Res A 88(4):216-222.
Bonham C, et al. 2018. Asthma Outcomes and Management During Pregnancy. Chest. 153(2):515-527.
Chaumont M et al. 2019. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol. 2019 May 1; 316(5): L705–L719.
Crowe H M, et al. 2020. Association of Asthma Diagnosis and Medication Use with Fecundability: A Prospective Cohort Study. Clinical Epidemiology, 12, 579–587.
Davies G, et al. 2020. Medicines prescribed for asthma, discontinuation. and perinatal outcomes, including breastfeeding: A population cohort analysis. PloS One, 15(12), e0242489.
Garne E, et al. 2015. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study. J Allergy Clin Immunol. Jul 25. pii: S0091-6749(15)00837-4.
Han V X, et al.2021. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: A systematic review. Translational Psychiatry, 11(1), 71.
Howley M. M., et al., & National Birth Defects Prevention Study. 2020. Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011. The Journal of Allergy and Clinical Immunology. In Practice, 8(10), 3490-3499.e9.
Jöud A, ET AL. 2022. Infertility, pregnancy loss and assisted reproduction in women with asthma: a population-based cohort study. Hum Reprod ;37(12):2932-2941.
Kallen B, 2007. The safety of asthma medications during pregnancy. Expert Opin Drug Saf 6(1):15-26.
Kwon HL, et al. 2006. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 26(1):29-62.
Liu X, et al. 2019. Parental asthma occurrence, exacerbations, and risk of attention-deficit/hyperactivity disorder. Brain, Behavior, and Immunity, 82, 302–308.
Longo C, et al. 2020. Timing of Maternal Asthma Diagnosis in Relation to Adverse Perinatal Outcomes. The Journal of Allergy and Clinical Immunology. In Practice, 8(6), 1938-1946.e4.
Mehta N, et al. 2015. Respiratory disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 29(5):598-611.
Middleton P G, et al. 2020. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. European Respiratory Journal, 55(2).
Murphy VE, et al. 2005. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir 25:731-750.
Namazy JA, Schatz M. 2015. Pharmacotherapy options to treat asthma during pregnancy. Expert Opin Pharmacother;16(12):1783-91.
National Asthma Education and Prevention Program. Working Group. 2004. Report on managing asthma during pregnancy: Recommendations for pharmacologic treatment. Update 2004. NIH publication NO.05-5236. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute.
Rejnö G, et al. 2019. Maternal anxiety, depression and asthma and adverse pregnancy outcomes – a population based study. Sci Rep. Sep 11;9(1):13101. doi: 10.1038/s41598-019-49508-z
Robijn AL, et al. 2019. Inhaled corticosteroid use during pregnancy among women with asthma: A systematic review and meta-analysis. Clin Exp Allergy. 2019 Jul 29. doi: 10.1111/cea.13474. [Epub ahead of print]
Robijn AL, et al. 2020. Effect of maternal asthma exacerbations on perinatal outcomes: a population-based study. ERJ open research, 6(4).
Robijn AL, et al. 2024. Adverse neonatal outcomes in pregnant women with asthma: An updated systematic review and meta-analysis. Int J Gynaecol Obstet, 166(2):596-606.
Roff AJ, et al. 2024 Maternal asthma during pregnancy and risks of allergy and asthma in progeny: A systematic review and meta-analysis. BJOG.
Schatz M, Dombrowski MP 2009. Clinical practice: Asthma in pregnancy. N Engl J Med 360(18):1862-1869.
Tidemandsen C, et al. 2022. Asthma Is Associated With Pregnancy Loss and Recurrent Pregnancy Loss: A Nationwide Cohort Study. J Allergy Clin Immunol Pract. 10(9):2326-2332.e3.
Vanders RL, Murphy VE. 2015. Maternal complications and the management of asthma in pregnancy. Womens Health (Lond Engl);11(2):183-91.
Vejen Hansen, A, et al. 2019. Fertility treatment among women with asthma: A case-control study of 3689 women with live births. The European Respiratory Journal, 53(2), 1800597.
Wang, M., et al.2020. Maternal asthma and the risk of hypertensive disorders of pregnancy: A systematic review and meta-analysis of cohort studies. Hypertension in Pregnancy, 39(1), 12–24.
Wasilewska E, & Małgorzewicz, S. 2019. Impact of allergic diseases on fertility. Postepy Dermatologii I Alergologii, 36(5), 507–512.
Yland J J, et al. 2020. Perinatal Outcomes Associated with Maternal Asthma and Its Severity and Control During Pregnancy. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 1928-1937.e3.

Iodine

Selected References:

Alwan S, et al. 2007. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356(26):2684-2692.
Alwan S, Friedman JM, Chambers C: 2016. Safety of selective serotonin reuptake inhibitors in pregnancy: a review of current evidence. CNS Drugs 30(6):499-515.
Andrade S, et al. 2009. Antidepressant use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18(3):246-252.
Bakker MK, et al. 2010. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 88(2):94-100.
Berard A, et al. 2016. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: A systematic review and meta-analysis. Br J Clin Pharmacol; 81(4):589-604.
Berard A, et al. 2017. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: An updated analysis of the Quebec Pregnancy Cohort. BMJ Open;7:e013372.
Biffi, A, et al. 2020. Use of antidepressants during pregnancy and neonatal outcomes: An umbrella review of meta-analyses of observational studies. Journal of Psychiatric Research, 124:99–108.
Bonari L, et al. 2004. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 49(11):726-735.
Chambers C, et al. 2006. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6)579-587.
Costei A, et. al. 2002. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 156:1129-1132.
Creeley, C. E., & Denton, L. K. 2019. Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes. Brain Sciences, 9(9)::235
Den Besten-Bertholee D, et al. 2024. Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure. Front Pharmacol.15:1414677.
Desaunay P, et al. 2023. Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses. Paediatr Drugs. 25(3):247-265.
De Vries, C., et al. 2020. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants. Drug Safety. https://doi.org/10.1007/s40264-020-01027
Diav-Citrin O, et al. 2008. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled observational study. Br J Clin Pharmacol 66(5): 695-705.
Einarson A, et al. 2008. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry AiA:1-5.
Einarson A, et al. 2009. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can 31:452-456.
Fischer Fumeaux, CJ, et al. 2019. Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence – an update. Expert Opinion on Drug Safety, 18(10):949–963.
Fitton, CA, et al. 2020. In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review. Acta Psychiatrica Scandinavica, 141(1): 21–33.
Gabriel M & Sharma V. 2017. Antidepressant discontinuation syndrome. CMAJ;189:E747.
Galbally, M., et al. 2020. Antidepressant exposure in pregnancy and child sensorimotor and visuospatial development. Journal of Psychiatric Research;S0022-3956(20)31095-5.
Gao S, et al. 2018. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 16:205.
Grigoriadis S et al. 2013. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence.J Clin Psychiatry. 74(4):e293-308.
Hansen CH, et al. 2017. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line. Toxicol In Vitro. 41:1-11
Hendrick V, et al. 2001. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 179:163-166
Hernandez-Diaz S. 2007. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 120 (2):e272-282.
Jordan S, et al. 2016. Selective serotonin reuptake inhibitor (SSRI) in pregnancy and congenital anomalies: Analysis of linked databases in Wales, Norway and Funen, Denmark. PLOS One; 11(12): e0165122.
Kallen B, et al. 2008. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 17(8):801-806.
Kieviet N, et al. 2015. Risk factors for poor neonatal adaptation after exposure to antidepressants in utero. Acta Paediatr.104(4):384-91.
Lebin LG, Novick AM. 2022. Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child. Curr Psychiatry Rep: 24, 687–695.
Leerssen, E. C. M., et al. 2019. Severe transient neonatal long QT syndrome due to maternal paroxetine usage: a case report. Cardiology in the Young, 29(10), 1300–1301. https://doi.org/10.1017/S1047951119001938
Levinson-Castiel R, et al. 2006. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 160:173-176.
Louik C, et al. 2007. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356(26):2675-2683.
McDonagh MS, et al. 2014. Antidepressant treatment of depression during pregnancy and the postpartum period. Evidence report/technology assessment No. 216. (Prepared by the Pacific Northwest Evidnece-based Practice Center under Contract No. 290-2007-10057-I.). Rockville, MD: Agency for Healthcare Research and Quality.
Mesches, G. A., et al. 2020. A common clinical conundrum: Antidepressant treatment of depression in pregnant women. Seminars in Perinatology, 44(3), 151229. https://doi.org/10.1016/j.semperi.2020.151229
Misri S, et al. 2000. Paroxetine levels in postpartum depressed women, breastmilk, and infant serum. J Clin Psychiatry 61(11):828-832.
Molenaar, N. M., et al. 2018. Guidelines on treatment of perinatal depression with antidepressants: An international review. The Australian and New Zealand Journal of Psychiatry, 52(4), 320–327.
Myles N, et al. 2013. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations. Aust N Z J Psychiatry.47(11):1002-12.
Nakhai-Pour HR, et al. 2010. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 182(10):1031-1037.
Nulman I, et al. 1997. Neurodevelopment of children exposed in utero to antidepressant drugs. NEJM 336(4):258-262.
Nulman I, et al. 2012.Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012 169(11):1165-1174.
Ornoy, A., & Koren, G. 2018. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects. Expert Opinion on Drug Metabolism & Toxicology, 14(3), 247–259. https://doi.org/10.1080/17425255.2018.1430139
Ornoy A, Koren G. 2014. Selective serotonin reuptake inhibitors in human pregnancy: On the way to resolving the controversy. Semin Fetal Neonatal Med. 19(3):188-194.
Orsolini L, Bellantuono C. 2015. Serotonin reuptake inhibitors and breastfeeding: A systematic review. Hum Psychopharmacol. 30:4-20.
Paxil Prescribing Information, 020936s047lbl.pdf. (n.d.). Retrieved January 7, 2021, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020936s047lbl.pdf
Pogliani L, Baldelli S, Cattaneo D et al. Selective serotonin reuptake inhibitors passage into human milk of lactating women. J Matern Fetal Neonatal Med. 2018;1-11.
Prady, S. L., et al. 2018. A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring’s outcomes. Archives of Women’s Mental Health, 21(2), 127–140.
Raffi, E. R., et al. 2019. Safety of Psychotropic Medications During Pregnancy. Clinics in Perinatology, 46(2), 215–234.
Sanz E, et al. 2005. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365:482-487.
Schoretsanitis G, et al. 2020. The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis. Expert Opin Drug Metab Toxicol.16(5):431-440.
Stowe Z, et al. 2000. Paroxetine in human breastmilk and nursing infants. Am J Psychiatry 157(2):185-189.
Tanrikut, C., et al. 2010. Adverse effect of paroxetine on sperm. Fertility and Sterility, 94(3), 1021–1026.
Tosounidou, S., & Gordon, C. 2020. Medications in pregnancy and breastfeeding. Best Practice & Research. Clinical Obstetrics & Gynaecology, 64, 68–76.
Trifu, S. C., et al. 2020. Affective disorders: A question of continuing treatment during pregnancy (Review). Experimental and Therapeutic Medicine, 20(4), 3474–3482.
Uguz, F. 2020. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses. Expert Opinion on Drug Safety, 19(12), 1595–1604.
Uguz F, Arpaci N. 2016. Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital. Breastfeed Med.11:487-9.
Uguz F. 2019. Short-term safety of paroxetine plus low-dose mirtazapine during lactation. Breastfeed Med. 14(2):131-132.
Wang S, et al. 2015. Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies. Journal of the American Heart Association. 4(5).
Weissman AM, et al. 2004. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry June; 161(6): 1066- 1078.
Wichman CL, et al. 2009. Congenital heart diease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo CLin Proc 84(1):23- 27.
Wurst K, et al. 2010. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol 88(3):159-170
Yardimci, A., et al. 2019. Effects of long-term paroxetine or bupropion treatment on puberty onset, reproductive and feeding parameters in adolescent male rats. Andrologia, 51(6), e13268.
Zheng L, Yang H, Dallmann A. 2022. Antidepressants and Antipsychotics in Human Pregnancy: Transfer Across the Placenta and Opportunities for Modeling Studies. J Clin Pharmacol. 62 Suppl 1:S115-S128.